Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis in Transthyretin (TTR)”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Large-scale testing (Phase 3)Looking for participantsNCT07052903
What this trial is testing

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals 1,750
Large-scale testing (Phase 3)Study completedNCT01994889
What this trial is testing

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Pfizer 441
Large-scale testing (Phase 3)Study completedNCT03862807
What this trial is testing

Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant

Who this might be right for
Amyloidosis, FamilialTransthyretin Amyloidosis
Alnylam Pharmaceuticals 24
Not applicableLooking for participantsNCT06845644
What this trial is testing

Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients

Who this might be right for
Charcot-Marie-Tooth Neuropathy Type 1AHereditary Transthyretin Amyloid NeuropathyAcquired Demyelinating Neuropathy
Assistance Publique Hopitaux De Marseille 120
Not applicableLooking for participantsNCT06836011
What this trial is testing

Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.

Who this might be right for
ATTR Amyloidosis With CardiomyopathyATTR-CMATTR Amyloidosis Wild Type+2 more
Medical University of Vienna 600
Testing effectiveness (Phase 2)Study completedNCT05635045
What this trial is testing

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

Who this might be right for
Transthyretin Amyloidosis
Columbia University 10
Early research (Phase 1)Ended earlyNCT03336580
What this trial is testing

PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis

Who this might be right for
Amyloidogenic Transthyretin (ATTR) Amyloidosis
Prothena Biosciences Limited 21
Large-scale testing (Phase 3)Study completedNCT03997383
What this trial is testing

APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 360
Not applicableStudy completedNCT06321523
What this trial is testing

Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT00694161
What this trial is testing

The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy

Who this might be right for
Cardiomyopathy
Pfizer 35
Not applicableStudy completedNCT05311488
What this trial is testing

Early Detection of Neuropathy in ATTRv

Who this might be right for
Hereditary Amyloidosis, Transthyretin-Related
University of Pennsylvania 47
Post-approval studies (Phase 4)Ended earlyNCT04306510
What this trial is testing

Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN

Who this might be right for
Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics 8
Not applicableStudy completedNCT05560555
What this trial is testing

Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.

Who this might be right for
Hereditary Transthyretin Amyloidosis (ATTRv)Polyneuropathy
Pfizer 5
Large-scale testing (Phase 3)Active Not RecruitingNCT06194825
What this trial is testing

EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
AstraZeneca 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT06260709
What this trial is testing

A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

Who this might be right for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S 80
Not applicableNot Yet RecruitingNCT07343999
What this trial is testing

EFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac Amyloidosis

Who this might be right for
Transthyretin Cardiac Amyloidosis
Universidad de Burgos 102
Testing effectiveness (Phase 2)Study completedNCT02191826
What this trial is testing

Study of SOM0226 in Familial Amyloid Polyneuropathy

Who this might be right for
Familial Amyloid Polyneuropathy (FAP)
SOM Innovation Biotech SA 17
Early research (Phase 1)Study completedNCT05661916
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects

Who this might be right for
Transthyretin-Mediated Amyloidosis
Alnylam Pharmaceuticals 96
Not applicableActive Not RecruitingNCT07494656
What this trial is testing

A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

Who this might be right for
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT01981837
What this trial is testing

Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis

Who this might be right for
TTR-mediated Amyloidosis
Alnylam Pharmaceuticals 26
Next Page